Delcuf D Syrup

Introduction

Delcuf D is a medication that contains the active ingredient pheniramine. It is available in the form of a syrup and is commonly prescribed to treat various allergic conditions.

Uses

Delcuf D is typically prescribed to alleviate symptoms associated with allergies, such as sneezing, itching, watery eyes, and runny nose. It can be used to manage symptoms related to hay fever, allergic rhinitis, and other allergic reactions.

Dosage and Administration

The dosage of Delcuf D may vary depending on the age, weight, and severity of the condition being treated. Follow the instructions provided by your healthcare professional or the directions on the product label. Typically, the recommended dosage for adults and children over 12 years of age is 5-10 mL of syrup, taken every 4 to 6 hours as needed. For children between 6 and 12 years old, the recommended dosage is 2.5-5 mL every 4 to 6 hours as needed.

Use the provided measuring device to ensure accurate dosing. Shake the syrup well before each use. If you have any questions regarding the dosage or administration, consult your healthcare provider.

Mechanism of Action

Pheniramine, the active ingredient in Delcuf D, belongs to a class of medications called antihistamines. It works by blocking the effects of histamine, a substance in the body that is responsible for causing allergy symptoms. By inhibiting the action of histamine, pheniramine helps relieve symptoms such as itching, sneezing, and runny nose.

Side Effects

Common side effects may include drowsiness, dizziness, dry mouth, and blurred vision. These side effects are usually mild and temporary. However, if these side effects persist or worsen, consult your healthcare provider.

In rare cases, Delcuf D may cause more serious side effects. These may include rapid or irregular heartbeat, difficulty urinating, confusion, or hallucinations. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

Delcuf D may interact with other medications, including sedatives, tranquilizers, and certain antidepressants. Inform your healthcare provider about all the medications, supplements, and herbal products you are taking before starting Delcuf D. This will help prevent any potential drug interactions and ensure your safety.

Precautions

Before taking Delcuf D, inform your healthcare provider if you have any medical conditions, such as glaucoma, urinary retention, or asthma. Disclose any allergies or sensitivities you may have, as well as any other medications you are currently taking.

Delcuf D is not recommended for use in children under the age of 6 years. Follow the age-specific dosage instructions provided by your healthcare professional.

Storage

Store Delcuf D in a cool, dry place, away from direct sunlight and heat. Keep the medication out of reach of children and pets. Do not store it in the bathroom or near the kitchen sink. Check the product label for specific storage instructions and expiration date information.

Patient Tips

• Take Delcuf D as directed by your healthcare provider or as indicated on the product label.
• If you experience drowsiness or dizziness while taking this medication, avoid driving or operating heavy machinery.
• Avoid consuming alcohol or other sedatives while taking Delcuf D, as it may increase the risk of drowsiness and other side effects.
• If you have any concerns or questions about Delcuf D, consult your healthcare provider for further guidance and information.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Pheniramine and phenylephrine (Drugs.com) [Accessed 24 Jun. 2024] (online) Available at:
• alahist dm(pheniramine) 12.5 mg-5 mg-10 mg/5 ml oral liquid antitussives (OTC) [Accessed 14 Jun. 2024] (online) Available at:
• Pheniramine overdose (MedlinePlus) [Accessed 13 Jun. 2024] (online) Available at:
• Bhandutia DK, Nayok SB, Akshatha H S D, Thimmaiah SM. Pheniramine dependence in obsessive-compulsive disorder: A case report. Int J Risk Saf Med. 2022;33(1):23-26. doi: 10.3233/JRS-200053. [Accessed 24 Jun. 2024] Available at: